Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04507516 · ClinicalTrials.gov registry record
Fasting for Brain and Heart Health (FBHH)
A clinical trial of Insulin Resistance, sponsored by TrueNorth Health Foundation.
- Completed
- Registry status
- 48
- Enrollment target
- 1
- Study location
NCT04507516: Completed study of Insulin Resistance, sponsored by TrueNorth Health Foundation.
NCT04507516 is a study of Insulin Resistance that has completed, run by TrueNorth Health Foundation. The registered enrollment target is 48 participants, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04507516, a study of Insulin Resistance, has completed, sponsored by TrueNorth Health Foundation.
- COMPLETED
- Registry status
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot study is designed to investigate the effect of water-only fasting and refeeding on the homeostatic model of insulin resistance (HOMA-IR), a measure of insulin resistance.
Primary Outcome
Insulin resistance assessed using serum glucose and insulin to calculate homeostatic model of insulin resistance (HOMA-IR) \[fasting insulin (microU/L) x fasting glucose (nmol/L)/22.5\]
Conditions Studied
Interventions
- OTHER Water-only Fasting
Study Locations (1)
California
- TrueNorth Health Center - Santa Rosa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2019-04-02 |
| Est. Completion | 2020-02-10 |
What the finished NCT04507516 record still lists
NCT04507516 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Insulin Resistance appearing as the primary indexed condition, and to 1 intervention - of which Water-only Fasting is the first listed.
NCT04507516 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04507516 about?
NCT04507516 is a clinical study titled "Fasting for Brain and Heart Health (FBHH)". This pilot study is designed to investigate the effect of water-only fasting and refeeding on the homeostatic model of insulin resistance (HOMA-IR), a measure of insulin resistance.
What is the current status of trial NCT04507516?
This trial is currently completed. The enrollment target is 48 participants. The study started on 2019-04-02. Estimated completion is 2020-02-10.
What conditions does trial NCT04507516 study?
This clinical trial studies the following conditions: Insulin Resistance.
What interventions are being tested in trial NCT04507516?
The interventions under investigation include: Water-only Fasting (OTHER).
Who is sponsoring clinical trial NCT04507516?
This trial is sponsored by TrueNorth Health Foundation, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04507516 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insulin Resistance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04507516's enrollment target sits among peer trials
48 63rd of 120 higher than 58 of 120 other Insulin Resistance trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insulin Resistance trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Small Extracellular Vesicles and Insulin Action
RECRUITING · NA
-
Metabolic Effects of Angiotensin-(1-7)
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI